Menu
Currency
GWAS Study

Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.

Demontis D, Walters RK, Martin J et al.

30478444 PubMed ID
GWAS Study Type
267831 Participants
130 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

DD
Demontis D
WR
Walters RK
MJ
Martin J
MM
Mattheisen M
AT
Als TD
AE
Agerbo E
BG
Baldursson G
BR
Belliveau R
BJ
Bybjerg-Grauholm J
BM
Bækvad-Hansen M
CF
Cerrato F
CK
Chambert K
CC
Churchhouse C
DA
Dumont A
EN
Eriksson N
GM
Gandal M
GJ
Goldstein JI
GK
Grasby KL
GJ
Grove J
GO
Gudmundsson OO
HC
Hansen CS
HM
Hauberg ME
HM
Hollegaard MV
HD
Howrigan DP
HH
Huang H
MJ
Maller JB
MA
Martin AR
MN
Martin NG
MJ
Moran J
PJ
Pallesen J
PD
Palmer DS
PC
Pedersen CB
PM
Pedersen MG
PT
Poterba T
PJ
Poulsen JB
RS
Ripke S
RE
Robinson EB
SF
Satterstrom FK
SH
Stefansson H
SC
Stevens C
TP
Turley P
WG
Walters GB
WH
Won H
WM
Wright MJ
AO
Andreassen OA
AP
Asherson P
BC
Burton CL
BD
Boomsma DI
CB
Cormand B
DS
Dalsgaard S
FB
Franke B
GJ
Gelernter J
GD
Geschwind D
HH
Hakonarson H
HJ
Haavik J
KH
Kranzler HR
KJ
Kuntsi J
LK
Langley K
LK
Lesch KP
MC
Middeldorp C
RA
Reif A
RL
Rohde LA
RP
Roussos P
SR
Schachar R
SP
Sklar P
SE
Sonuga-Barke EJS
SP
Sullivan PF
TA
Thapar A
TJ
Tung JY
WI
Waldman ID
MS
Medland SE
SK
Stefansson K
NM
Nordentoft M
HD
Hougaard DM
WT
Werge T
MO
Mors O
MP
Mortensen PB
DM
Daly MJ
FS
Faraone SV
BA
Børglum AD
NB
Neale BM
Chapter II

Abstract

Summary of the research findings

Attention deficit/hyperactivity disorder (ADHD) is a highly heritable childhood behavioral disorder affecting 5% of children and 2.5% of adults. Common genetic variants contribute substantially to ADHD susceptibility, but no variants have been robustly associated with ADHD. We report a genome-wide association meta-analysis of 20,183 individuals diagnosed with ADHD and 35,191 controls that identifies variants surpassing genome-wide significance in 12 independent loci, finding important new information about the underlying biology of ADHD. Associations are enriched in evolutionarily constrained genomic regions and loss-of-function intolerant genes and around brain-expressed regulatory marks. Analyses of three replication studies: a cohort of individuals diagnosed with ADHD, a self-reported ADHD sample and a meta-analysis of quantitative measures of ADHD symptoms in the population, support these findings while highlighting study-specific differences on genetic overlap with educational attainment. Strong concordance with GWAS of quantitative population measures of ADHD symptoms supports that clinical diagnosis of ADHD is an extreme expression of continuous heritable traits.

19,099 European ancestry cases, 72 non-European ancestry cases, 1,012 Han Chinese ancestry cases, 34,194 European ancestry controls, 72 non-European ancestry controls, 925 Han Chinese ancestry controls

Chapter III

Study Statistics

Key metrics and study information

267831
Total Participants
GWAS
Study Type
Yes
Replicated
5,085 Icelandic ancestry cases, 5,857 cases, 131,122 Icelandic ancestry controls, 70,393 controls
Replication Participants
East Asian, European
Ancestry
China, Iceland, Canada, U.S., Belgium, Germany, Netherlands, Switzerland, Israel, Denmark, Republic of Ireland, Norway, U.K., Spain
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.